• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI 0.00% 1.1¢

ALGORAE PHARMACEUTICALS LIMITED - Announcements

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

Announcements


1AI Ceasing to be a substantial holder-LCT.AX 07/04/16 download Created with Sketch. 133.38KB
1AI Appendix 3B-LCT.AX 06/04/16 download Created with Sketch. 508.24KB
1AI LCT share purchase plan raises $0.5m-LCT.AX 04/04/16 download Created with Sketch. 314.98KB
1AI LCT starts Phase IIb clinical trial of NTCELLPRICE SENSITIVE24/03/16 download Created with Sketch. 332.92KB
1AI Extension of SPP Closing Date to 29 March 201609/03/16 download Created with Sketch. 230.44KB
1AI Half Yearly Report and AccountsPRICE SENSITIVE26/02/16 download Created with Sketch. 776.28KB
1AI Dispatch of Share Purchase Plan Offer Documents23/02/16 download Created with Sketch. 584.27KB
1AI Becoming a substantial holder19/02/16 download Created with Sketch. 151.06KB
1AI Cleansing Statement18/02/16 download Created with Sketch. 193.32KB
1AI Appendix 3B18/02/16 download Created with Sketch. 200.93KB
1AI LCT completes $2.8m private placement and announces SPPPRICE SENSITIVE17/02/16 download Created with Sketch. 81.11KB
1AI LCT receives ethics approval for Phase IIb Parkinsons trialPRICE SENSITIVE03/02/16 download Created with Sketch. 76.41KB
1AI NTCELL reverses the progression of Parkinsons diseasePRICE SENSITIVE27/01/16 download Created with Sketch. 87.35KB
1AI Commentary on Appendix 4C - 31 December 2015PRICE SENSITIVE12/01/16 download Created with Sketch. 72.11KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE12/01/16 download Created with Sketch. 97.39KB
1AI Change of Company Secretary, Registered Office Address05/01/16 download Created with Sketch. 35.84KB
1AI LCT complies with ASIC infringement noticePRICE SENSITIVE18/12/15 download Created with Sketch. 51.91KB
1AI LCT secures supply of NTCELLPRICE SENSITIVE02/12/15 download Created with Sketch. 48.3KB
1AI Special CEO Update18/11/15 download Created with Sketch. 284.96KB
1AI Update on clinical trials of encapsulated pig isletsPRICE SENSITIVE16/11/15 download Created with Sketch. 3.18MB
1AI Results of Annual General Meeting13/11/15 download Created with Sketch. 50.86KB
1AI CEO Presentation to Annual General Meeting12/11/15 download Created with Sketch. 1.12MB
1AI Minister authorises Phase IIb Parkinson's studyPRICE SENSITIVE12/11/15 download Created with Sketch. 50.17KB
1AI FY15 Annual Report - Rectification to Auditor's Report11/11/15 download Created with Sketch. 151.16KB
1AI NTCELL - Parkinson's trial 42 week resultPRICE SENSITIVE27/10/15 download Created with Sketch. 49.06KB
1AI Commentary on Appendix 4C - 30 September 201514/10/15 download Created with Sketch. 48.78KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE14/10/15 download Created with Sketch. 51.13KB
1AI Annual Report to shareholders09/10/15 download Created with Sketch. 3.03MB
1AI Notice of Annual General Meeting/Proxy Form09/10/15 download Created with Sketch. 498.46KB
1AI Change of Director's Interest Notice15/09/15 download Created with Sketch. 22.04KB
1AI Change of Director's Interest Notice03/09/15 download Created with Sketch. 22.01KB
1AI LCT to receive Callaghan Innovation Growth GrantPRICE SENSITIVE28/08/15 download Created with Sketch. 49.23KB
1AI Preliminary Final Report 30 June 201519/08/15 download Created with Sketch. 49.04KB
1AI Appendix 4E and Financial Statements YE 30 June 2015PRICE SENSITIVE19/08/15 download Created with Sketch. 670.18KB
1AI LCT planning to resume control of NTCELL manufacturePRICE SENSITIVE18/08/15 download Created with Sketch. 48.75KB
1AI Living Insights Newsletter05/08/15 download Created with Sketch. 1.11MB
1AI Response to ASX aware letterPRICE SENSITIVE29/07/15 download Created with Sketch. 385.73KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE27/07/15 download Created with Sketch. 493.17KB
1AI Proposed grant of options to Directors14/07/15 download Created with Sketch. 272.63KB
1AI Update to DIABECELL development strategyPRICE SENSITIVE26/06/15 download Created with Sketch. 49.36KB
1AI LCT hosts conference call on Clinical Study in Parkinson's18/06/15 download Created with Sketch. 26.69KB
1AI Parkinson's Congress NTCELL Poster Presentation16/06/15 download Created with Sketch. 1.08MB
1AI NTCELL Clinical Study - Investor Conf. Call Time Correction15/06/15 download Created with Sketch. 17.41KB
1AI NTCELL Clinical Study in Parkinson's Meets EndpointsPRICE SENSITIVE15/06/15 download Created with Sketch. 31.09KB
1AI Trading HaltPRICE SENSITIVE12/06/15 download Created with Sketch. 49.25KB
1AI CEO Remuneration05/06/15 download Created with Sketch. 47.92KB
1AI LCT JV adopts new strategy for DIABECELLPRICE SENSITIVE05/03/15 download Created with Sketch. 39.07KB
1AI Professor Elliott steps down from executive position24/02/15 download Created with Sketch. 270.39KB
1AI Half Yearly Report and AccountsPRICE SENSITIVE18/02/15 download Created with Sketch. 338.53KB
1AI Appendix 3B02/02/15 download Created with Sketch. 50.5KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE28/01/15 download Created with Sketch. 100.74KB
1AI Change of Registered Office Address19/01/15 download Created with Sketch. 21.11KB
1AI LCT completes patient implants in Parkinson's trialPRICE SENSITIVE15/12/14 download Created with Sketch. 21.96KB
1AI Amended Appendix 3B09/12/14 download Created with Sketch. 106.7KB
1AI Share Purchase Plan-Cleansing Notice08/12/14 download Created with Sketch. 13.82KB
1AI Appendix 3B08/12/14 download Created with Sketch. 106.71KB
1AI LCT share purchase plan raises $1.08m04/12/14 download Created with Sketch. 21.49KB
1AI Results of Annual General Meeting18/11/14 download Created with Sketch. 51.14KB
1AI CEO Presentation to 2014 AGM18/11/14 download Created with Sketch. 675.37KB
1AI Chairman's Presentation to 2014 AGM18/11/14 download Created with Sketch. 324.81KB
1AI Chairman's Address to 2014 AGM18/11/14 download Created with Sketch. 23.79KB
1AI Recruitment of all patients in Parkinson's trial completed03/11/14 download Created with Sketch. 272.88KB
1AI Appendix 4C 30 Sep 2014PRICE SENSITIVE28/10/14 download Created with Sketch. 96.33KB
1AI LCT Share Purchase Plan extended to 28 November 201428/10/14 download Created with Sketch. 48.05KB
1AI Notice of Annual General Meeting/Proxy Form17/10/14 download Created with Sketch. 345.2KB
1AI Annual Report to shareholders17/10/14 download Created with Sketch. 1.27MB
1AI Share Purchase Plan Offer Terms and Conditions15/10/14 download Created with Sketch. 471.17KB
1AI Change in substantial holding14/10/14 download Created with Sketch. 95.95KB
1AI Cleansing Statement10/10/14 download Created with Sketch. 13.9KB
1AI LCT JV secures funds to realise the potential of DIABECELLPRICE SENSITIVE10/10/14 download Created with Sketch. 62.18KB
1AI Appendix 3B08/10/14 download Created with Sketch. 383.15KB
1AI Completion of $3m placement and SPP announcedPRICE SENSITIVE08/10/14 download Created with Sketch. 279.03KB
1AI LCT collaborates to develop novel neurological treatments29/09/14 download Created with Sketch. 35.62KB
1AI LCT Appoints Scientific Advisors23/09/14 download Created with Sketch. 17KB
1AI 2014 Annual General Meeting and Director Nominations16/09/14 download Created with Sketch. 48.29KB
1AI Successful second implant of NTCELL for Parkinson'sPRICE SENSITIVE18/08/14 download Created with Sketch. 48.63KB
1AI Preliminary Final Report 30 June 201415/08/14 download Created with Sketch. 311.17KB
1AI Appendix 4E and Financial StatementsPRICE SENSITIVE15/08/14 download Created with Sketch. 481.12KB
1AI Change of Director's Interest Notice01/08/14 download Created with Sketch. 34.23KB
1AI Appendix 4C Announcement30/07/14 download Created with Sketch. 48.42KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE30/07/14 download Created with Sketch. 51.17KB
1AI Chief Executive's Remuneration08/07/14 download Created with Sketch. 47.83KB
1AI Dr Ken Taylor appointed Chief ExecutivePRICE SENSITIVE08/07/14 download Created with Sketch. 66.12KB
1AI Change of Director's Interest Notice25/06/14 download Created with Sketch. 22.01KB
1AI LCT Parkinson's trial resumes patient recruitmentPRICE SENSITIVE23/06/14 download Created with Sketch. 62KB
1AILCT to develop NTCELL independentlyPRICE SENSITIVE15/05/14 download Created with Sketch. 61.96KB
1AIAppendix 4C - quarterlyPRICE SENSITIVE29/04/14 download Created with Sketch. 101.25KB
1AIFinal Director's Interest Notice01/04/14 download Created with Sketch. 25.88KB
1AILCT restructuresPRICE SENSITIVE01/04/14 download Created with Sketch. 273.88KB
1AIAppendix 4D and Half Year Financial ReportPRICE SENSITIVE25/02/14 download Created with Sketch. 313.69KB
1AIStatement on NTCELL Phase 1 Clinical Trial20/02/14 download Created with Sketch. 71.12KB
1AIAppointment of NTCELL Program Director06/02/14 download Created with Sketch. 92.08KB
1AIAppendix 4C Cash Flow Report 31 December 201329/01/14 download Created with Sketch. 48.7KB
1AIAppendix 4C - quarterlyPRICE SENSITIVE29/01/14 download Created with Sketch. 51.26KB
1AIChange in substantial holding23/01/14 download Created with Sketch. 294.87KB
1AIExecutive change21/01/14 download Created with Sketch. 60.74KB
1AIWithdrawal of NTCELL pre-clinical studyPRICE SENSITIVE19/12/13 download Created with Sketch. 276.5KB
1AIChange of Director's Interest Notice16/12/13 download Created with Sketch. 70.29KB
1AIChange of Director's Interest Notice16/12/13 download Created with Sketch. 69.95KB
1AIChange in substantial holding09/12/13 download Created with Sketch. 290.72KB
1AI Ceasing to be a substantial holder-LCT.AX
07/04/16 download Created with Sketch. 133.38KB
1AI Appendix 3B-LCT.AX
06/04/16 download Created with Sketch. 508.24KB
1AI LCT share purchase plan raises $0.5m-LCT.AX
04/04/16 download Created with Sketch. 314.98KB
1AI LCT starts Phase IIb clinical trial of NTCELL
24/03/16PRICE SENSITIVE download Created with Sketch. 332.92KB
1AI Extension of SPP Closing Date to 29 March 2016
09/03/16 download Created with Sketch. 230.44KB
1AI Half Yearly Report and Accounts
26/02/16PRICE SENSITIVE download Created with Sketch. 776.28KB
1AI Dispatch of Share Purchase Plan Offer Documents
23/02/16 download Created with Sketch. 584.27KB
1AI Becoming a substantial holder
19/02/16 download Created with Sketch. 151.06KB
1AI Cleansing Statement
18/02/16 download Created with Sketch. 193.32KB
1AI Appendix 3B
18/02/16 download Created with Sketch. 200.93KB
1AI LCT completes $2.8m private placement and announces SPP
17/02/16PRICE SENSITIVE download Created with Sketch. 81.11KB
1AI LCT receives ethics approval for Phase IIb Parkinsons trial
03/02/16PRICE SENSITIVE download Created with Sketch. 76.41KB
1AI NTCELL reverses the progression of Parkinsons disease
27/01/16PRICE SENSITIVE download Created with Sketch. 87.35KB
1AI Commentary on Appendix 4C - 31 December 2015
12/01/16PRICE SENSITIVE download Created with Sketch. 72.11KB
1AI Appendix 4C - quarterly
12/01/16PRICE SENSITIVE download Created with Sketch. 97.39KB
1AI Change of Company Secretary, Registered Office Address
05/01/16 download Created with Sketch. 35.84KB
1AI LCT complies with ASIC infringement notice
18/12/15PRICE SENSITIVE download Created with Sketch. 51.91KB
1AI LCT secures supply of NTCELL
02/12/15PRICE SENSITIVE download Created with Sketch. 48.3KB
1AI Special CEO Update
18/11/15 download Created with Sketch. 284.96KB
1AI Update on clinical trials of encapsulated pig islets
16/11/15PRICE SENSITIVE download Created with Sketch. 3.18MB
1AI Results of Annual General Meeting
13/11/15 download Created with Sketch. 50.86KB
1AI CEO Presentation to Annual General Meeting
12/11/15 download Created with Sketch. 1.12MB
1AI Minister authorises Phase IIb Parkinson's study
12/11/15PRICE SENSITIVE download Created with Sketch. 50.17KB
1AI FY15 Annual Report - Rectification to Auditor's Report
11/11/15 download Created with Sketch. 151.16KB
1AI NTCELL - Parkinson's trial 42 week result
27/10/15PRICE SENSITIVE download Created with Sketch. 49.06KB
1AI Commentary on Appendix 4C - 30 September 2015
14/10/15 download Created with Sketch. 48.78KB
1AI Appendix 4C - quarterly
14/10/15PRICE SENSITIVE download Created with Sketch. 51.13KB
1AI Annual Report to shareholders
09/10/15 download Created with Sketch. 3.03MB
1AI Notice of Annual General Meeting/Proxy Form
09/10/15 download Created with Sketch. 498.46KB
1AI Change of Director's Interest Notice
15/09/15 download Created with Sketch. 22.04KB
1AI Change of Director's Interest Notice
03/09/15 download Created with Sketch. 22.01KB
1AI LCT to receive Callaghan Innovation Growth Grant
28/08/15PRICE SENSITIVE download Created with Sketch. 49.23KB
1AI Preliminary Final Report 30 June 2015
19/08/15 download Created with Sketch. 49.04KB
1AI Appendix 4E and Financial Statements YE 30 June 2015
19/08/15PRICE SENSITIVE download Created with Sketch. 670.18KB
1AI LCT planning to resume control of NTCELL manufacture
18/08/15PRICE SENSITIVE download Created with Sketch. 48.75KB
1AI Living Insights Newsletter
05/08/15 download Created with Sketch. 1.11MB
1AI Response to ASX aware letter
29/07/15PRICE SENSITIVE download Created with Sketch. 385.73KB
1AI Appendix 4C - quarterly
27/07/15PRICE SENSITIVE download Created with Sketch. 493.17KB
1AI Proposed grant of options to Directors
14/07/15 download Created with Sketch. 272.63KB
1AI Update to DIABECELL development strategy
26/06/15PRICE SENSITIVE download Created with Sketch. 49.36KB
1AI LCT hosts conference call on Clinical Study in Parkinson's
18/06/15 download Created with Sketch. 26.69KB
1AI Parkinson's Congress NTCELL Poster Presentation
16/06/15 download Created with Sketch. 1.08MB
1AI NTCELL Clinical Study - Investor Conf. Call Time Correction
15/06/15 download Created with Sketch. 17.41KB
1AI NTCELL Clinical Study in Parkinson's Meets Endpoints
15/06/15PRICE SENSITIVE download Created with Sketch. 31.09KB
1AI Trading Halt
12/06/15PRICE SENSITIVE download Created with Sketch. 49.25KB
1AI CEO Remuneration
05/06/15 download Created with Sketch. 47.92KB
1AI LCT JV adopts new strategy for DIABECELL
05/03/15PRICE SENSITIVE download Created with Sketch. 39.07KB
1AI Professor Elliott steps down from executive position
24/02/15 download Created with Sketch. 270.39KB
1AI Half Yearly Report and Accounts
18/02/15PRICE SENSITIVE download Created with Sketch. 338.53KB
1AI Appendix 3B
02/02/15 download Created with Sketch. 50.5KB
1AI Appendix 4C - quarterly
28/01/15PRICE SENSITIVE download Created with Sketch. 100.74KB
1AI Change of Registered Office Address
19/01/15 download Created with Sketch. 21.11KB
1AI LCT completes patient implants in Parkinson's trial
15/12/14PRICE SENSITIVE download Created with Sketch. 21.96KB
1AI Amended Appendix 3B
09/12/14 download Created with Sketch. 106.7KB
1AI Share Purchase Plan-Cleansing Notice
08/12/14 download Created with Sketch. 13.82KB
1AI Appendix 3B
08/12/14 download Created with Sketch. 106.71KB
1AI LCT share purchase plan raises $1.08m
04/12/14 download Created with Sketch. 21.49KB
1AI Results of Annual General Meeting
18/11/14 download Created with Sketch. 51.14KB
1AI CEO Presentation to 2014 AGM
18/11/14 download Created with Sketch. 675.37KB
1AI Chairman's Presentation to 2014 AGM
18/11/14 download Created with Sketch. 324.81KB
1AI Chairman's Address to 2014 AGM
18/11/14 download Created with Sketch. 23.79KB
1AI Recruitment of all patients in Parkinson's trial completed
03/11/14 download Created with Sketch. 272.88KB
1AI Appendix 4C 30 Sep 2014
28/10/14PRICE SENSITIVE download Created with Sketch. 96.33KB
1AI LCT Share Purchase Plan extended to 28 November 2014
28/10/14 download Created with Sketch. 48.05KB
1AI Notice of Annual General Meeting/Proxy Form
17/10/14 download Created with Sketch. 345.2KB
1AI Annual Report to shareholders
17/10/14 download Created with Sketch. 1.27MB
1AI Share Purchase Plan Offer Terms and Conditions
15/10/14 download Created with Sketch. 471.17KB
1AI Change in substantial holding
14/10/14 download Created with Sketch. 95.95KB
1AI Cleansing Statement
10/10/14 download Created with Sketch. 13.9KB
1AI LCT JV secures funds to realise the potential of DIABECELL
10/10/14PRICE SENSITIVE download Created with Sketch. 62.18KB
1AI Appendix 3B
08/10/14 download Created with Sketch. 383.15KB
1AI Completion of $3m placement and SPP announced
08/10/14PRICE SENSITIVE download Created with Sketch. 279.03KB
1AI LCT collaborates to develop novel neurological treatments
29/09/14 download Created with Sketch. 35.62KB
1AI LCT Appoints Scientific Advisors
23/09/14 download Created with Sketch. 17KB
1AI 2014 Annual General Meeting and Director Nominations
16/09/14 download Created with Sketch. 48.29KB
1AI Successful second implant of NTCELL for Parkinson's
18/08/14PRICE SENSITIVE download Created with Sketch. 48.63KB
1AI Preliminary Final Report 30 June 2014
15/08/14 download Created with Sketch. 311.17KB
1AI Appendix 4E and Financial Statements
15/08/14PRICE SENSITIVE download Created with Sketch. 481.12KB
1AI Change of Director's Interest Notice
01/08/14 download Created with Sketch. 34.23KB
1AI Appendix 4C Announcement
30/07/14 download Created with Sketch. 48.42KB
1AI Appendix 4C - quarterly
30/07/14PRICE SENSITIVE download Created with Sketch. 51.17KB
1AI Chief Executive's Remuneration
08/07/14 download Created with Sketch. 47.83KB
1AI Dr Ken Taylor appointed Chief Executive
08/07/14PRICE SENSITIVE download Created with Sketch. 66.12KB
1AI Change of Director's Interest Notice
25/06/14 download Created with Sketch. 22.01KB
1AI LCT Parkinson's trial resumes patient recruitment
23/06/14PRICE SENSITIVE download Created with Sketch. 62KB
1AILCT to develop NTCELL independently
15/05/14PRICE SENSITIVE download Created with Sketch. 61.96KB
1AIAppendix 4C - quarterly
29/04/14PRICE SENSITIVE download Created with Sketch. 101.25KB
1AIFinal Director's Interest Notice
01/04/14 download Created with Sketch. 25.88KB
1AILCT restructures
01/04/14PRICE SENSITIVE download Created with Sketch. 273.88KB
1AIAppendix 4D and Half Year Financial Report
25/02/14PRICE SENSITIVE download Created with Sketch. 313.69KB
1AIStatement on NTCELL Phase 1 Clinical Trial
20/02/14 download Created with Sketch. 71.12KB
1AIAppointment of NTCELL Program Director
06/02/14 download Created with Sketch. 92.08KB
1AIAppendix 4C Cash Flow Report 31 December 2013
29/01/14 download Created with Sketch. 48.7KB
1AIAppendix 4C - quarterly
29/01/14PRICE SENSITIVE download Created with Sketch. 51.26KB
1AIChange in substantial holding
23/01/14 download Created with Sketch. 294.87KB
1AIExecutive change
21/01/14 download Created with Sketch. 60.74KB
1AIWithdrawal of NTCELL pre-clinical study
19/12/13PRICE SENSITIVE download Created with Sketch. 276.5KB
1AIChange of Director's Interest Notice
16/12/13 download Created with Sketch. 70.29KB
1AIChange of Director's Interest Notice
16/12/13 download Created with Sketch. 69.95KB
1AIChange in substantial holding
09/12/13 download Created with Sketch. 290.72KB
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $18.56M
Open High Low Value Volume
1.2¢ 1.2¢ 1.1¢ $117 10.41K

Buyers (Bids)

No. Vol. Price($)
7 1917185 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 1078999 5
View Market Depth
Last trade - 13.25pm 28/05/2024 (20 minute delay) ?
Last
1.1¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
1.1¢ 1.1¢ 1.1¢ 1000000
Last updated 13.25pm 28/05/2024 ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.